Pneumococcal Invasion: Development of Bacteremia and Meningitis

Streptococcus Pneumoniae: Molecular Mechanisms of Host-Pathogen Interactions

Volumn , Issue , 2015, Pages 433-451

  Gratz, Nina ^a   Loh, Lip Nam ^a   Tuomanen, Elaine ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Innate invasion; Meningitis; Neuronal damage; Sepsis

Indexed keywords

EID: 85045900717     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-410530-0.00023-5     Document Type: Chapter

References (110)

1. Henriques-Normark B., Tuomanen E.I. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med 2013, 3.
2. Feikin D.R., Kagucia E.W., Loo J.D., Link-Gelles R., Puhan M.A., Cherian T., et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013, 10:e1001517.
3. WHO Pneumococcal vaccines WHO position paper-2012-recommendations. Vaccine 2012, 30:4717-4718.
4. Hoogman M., van de Beek D., Weisfelt M., de Gans J., Schmand B. Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry 2007, 78:1092-1096.
5. Rose M.A., Christopoulou D., Myint T.T., de Schutter I. The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe. Int J Clin Pract 2014, 68:8-19.
6. Overturf G.D. Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis 1999, 14:191-218.
7. Miller M.L., Gao G., Pestina T., Persons D., Tuomanen E. Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor. J Infect Dis 2007, 195:581-584.
8. Rosch J.W., Boyd A.R., Hinojosa E., Pestina T., Hu Y., Persons D.A., et al. Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease. J Clin Invest 2010, 120:627-635.
9. Carter R., Wolf J., van Opijnen T., Muller M., Obert C., Burnham C., et al. Genomic analysis of pneumococci from children with sickle cell disease reveals disease specific bacterial adaptations and deficits in current clinical interventions. Cell Host Microbe 2014, 15:587-599.
10. Nelson A.L., Roche A.M., Gould J.M., Chim K., Ratner A.J., Weiser J.N. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun 2007, 75:83-90.
11. Weiser J.N., Austrian R., Sreenivasan P.K., Masure H.R. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994, 62:2582-2589.
12. Muñoz-Elías E.J., Marcano J., Camilli A. Isolation of Streptococcus pneumoniae biofilm mutants and their characterization during nasopharyngeal colonization. Infect Immun 2008, 76:5049-5061.
13. Tong H.H., Blue L.E., James M.A., DeMaria T.F. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun 2000, 68:921-924.
14. Mook-Kanamori B.B., Geldhoff M., van der Poll T., van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 2011, 24:557-591.
15. Weiser J.N., Bae D., Fasching C., Scamurra R.W., Ratner A.J., Janoff E.N. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci U S A 2003, 100:4215-4220.
16. Zhang J.R., Mostov K.E., Lamm M.E., Nanno M., Shimida S., Ohwaki M., et al. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000, 102:827-837.
17. Hammerschmidt S., Tillig M.P., Wolff S., Vaerman J.P., Chhatwal G.S. Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol 2000, 36:726-736.
18. Lu L., Lamm M.E., Li H., Corthesy B., Zhang J.R. The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. J Biol Chem 2003, 278:48178-48187.
19. Elm C., Braathen R., Bergmann S., Frank R., Vaerman J.P., Kaetzel C.S., et al. Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem 2004, 279:6296-6304.
20. Hammerschmidt S., Talay S.R., Brandtzaeg P., Chhatwal G.S. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol 1997, 25:1113-1124.
21. Agarwal V., Hammerschmidt S. Cdc42 and the phosphatidylinositol 3-kinase-Akt pathway are essential for PspC-mediated internalization of pneumococci by respiratory epithelial cells. J Biol Chem 2009, 284:19427-19436.
22. Asmat T.M., Agarwal V., Räth S., Hildebrandt J.P., Hammerschmidt S. Streptococcus pneumoniae infection of host epithelial cells via polymeric immunoglobulin receptor transiently induces calcium release from intracellular stores. J Biol Chem 2011, 286:17861-17869.
23. Barocchi M.A., Ries J., Zogaj X., Hemsley C., Albiger B., Kanth A., et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A 2006, 103:2857-2862.
24. Pancotto L., De Angelis G., Bizzarri E., Barocchi M.A., Del Giudice G., Moschioni M., et al. Expression of the Streptococcus pneumoniae pilus-1 undergoes on and off switching during colonization in mice. Sci Rep 2013, 3:2040.
25. Sanchez C.J., Shivshankar P., Stol K., Trakhtenbroit S., Sullam P.M., Sauer K., et al. The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog 2010, 6:e1001044.
26. Berry A.M., Paton J.C. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 2000, 68:133-140.
27. Tuomanen E., Rich R., Zak O. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am Rev Respir Dis 1987, 135:869-874.
28. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999, 163:1-5.
29. Tsuchiya K., Toyama K., Tsuprun V., Hamajima Y., Kim Y., Ondrey F.G., et al. Pneumococcal peptidoglycan-polysaccharides induce the expression of interleukin-8 in airway epithelial cells by way of nuclear factor-kappaB, nuclear factor interleukin-6, or activation protein-1 dependent mechanisms. Laryngoscope 2007, 117:86-91.
30. Geelen S., Bhattacharyya C., Tuomanen E. Induction of procoagulant activity on human endothelial cells by Streptococcus pneumoniae. Infect Immun 1992, 60:4179-4183.
31. Moschioni M., Donati C., Muzzi A., Masignani V., Censini S., Hanage W.P., et al. Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. J Infect Dis 2008, 197:888-896.
32. Thornton J.A., Durick-Eder K., Tuomanen E.I. Pneumococcal pathogenesis: "innate invasion" yet organ-specific damage. J Mol Med 2010, 88:103-107.
33. Kolberg J., Hoiby E.A., Jantzen E. Detection of the phosphorylcholine epitope in streptococci, Haemophilus and pathogenic Neisseriae by immunoblotting. Microb Pathog 1997, 22:321-329.
34. Gillespie S.H., Ainscough S., Dickens A., Lewin J. Phosphorylcholine-containing antigens in bacteria from the mouth and respiratory tract. J Med Microbiol 1996, 44:35-40.
35. Weiser J.N., Pan N., McGowan K.L., Musher D., Martin A., Richards J. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med 1998, 187:631-640.
36. Zhang J.R., Idanpaan-Heikkila I., Fischer W., Tuomanen E.I. Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol Microbiol 1999, 31:1477-1488.
37. Cundell D.R., Gerard N.P., Gerard C., Idanpaan-Heikkila I., Tuomanen E.I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995, 377:435-438.
38. Swords W.E., Buscher B.A., Ver Steeg Ii K., Preston A., Nichols W.A., Weiser J.N., et al. Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol 2000, 37:13-27.
39. Duitman J., Schouten M., Groot A.P., Daalhuisen J.B., Florquin S., van der Poll T., et al. CCAAT/enhancer-binding protein facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner. Proc Natl Acad Sci U S A 2012, 109:9113-9118.
40. Radin J.N., Orihuela C.J., Murti G., Guglielmo C., Murray P.J., Tuomanen E.I. Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae. Infect Immun 2005, 73:7827-7835.
41. Gould J.M., Weiser J.N. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J Infect Dis 2002, 186:361-371.
42. LeMessurier K.S., Hacker H., Chi L., Tuomanen E., Redecke V. Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung. PLoS Pathog 2013, 9:e1003727.
43. Beisswenger C., Coyne C.B., Shchepetov M., Weiser J.N. Role of p38 MAP kinase and transforming growth factor-beta signaling in transepithelial migration of invasive bacterial pathogens. J Biol Chem 2007, 282:28700-28708.
44. Beisswenger C., Lysenko E.S., Weiser J.N. Early bacterial colonization induces Toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immun 2009, 77:2212-2220.
45. Clarke T.B., Francella N., Huegel A., Weiser J.N. Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe 2011, 9:404-414.
46. Tilley S.J., Orlova E.V., Gilbert R.J., Andrew P.W., Saibil H.R. Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 2005, 121:247-256.
47. Hirst R.A., Kadioglu A., O'Callaghan C., Andrew P.W. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin Exp Immunol 2004, 138:195-201.
48. Lüttge M., Fulde M., Talay S.R., Nerlich A., Rohde M., Preissner K.T., et al. Streptococcus pneumoniae induces exocytosis of Weibel-Palade bodies in pulmonary endothelial cells. Cell Microbiol 2012, 14:210-225.
49. Spellerberg B., Cundell D.R., Sandros J., Pearce B.J., Idanpaan-Heikkila I., Rosenow C., et al. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol 1996, 19:803-813.
50. McCullers J.A., Bartmess K.C. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003, 187:1000-1009.
51. Standish A.J., Weiser J.N. Human neutrophils kill Streptococcus pneumoniae via serine proteases. J Immunol 2009, 183:2602-2609.
52. Mori Y., Yamaguchi M., Terao Y., Hamada S., Ooshima T., Kawabata S. Enolase of Streptococcus pneumoniae induces formation of neutrophil extracellular traps. J Biol Chem 2012, 287:10472-10481.
53. Beiter K., Wartha F., Albiger B., Normark S., Zychlinsky A., Henriques-Normark B. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr Biol 2006, 16:401-407.
54. Marks M., Burns T., Abadi M., Seyoum B., Thornton J., Tuomanen E., et al. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect Immun 2007, 75:1586-1597.
55. Brady A.M., Calix J.J., Yu J., Geno K.A., Cutter G.R., Nahm M.H. Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. J Infect Dis 2014, 210:1155-1165.
56. Li J., Glover D.T., Szalai A.J., Hollingshead S.K., Briles D.E. PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infect Immun 2007, 75:5877-5885.
57. Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008, 6:288-301.
58. Piet J.R., Geldhoff M., van Schaik B.D., Brouwer M.C., Valls Seron M., Jakobs M.E., et al. Streptococcus pneumoniae arginine synthesis genes promote growth and virulence in pneumococcal meningitis. J Infect Dis 2014.
59. Angus D.C., van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013, 369:840-851.
60. Van Amersfoort E.S., Van Berkel T.J., Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003, 16:379-414.
61. van der Poll T., Opal S.M. Host-pathogen interactions in sepsis. Lancet Infect Dis 2008, 8:32-43.
62. Hoffman O., Weber J.R. Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord 2009, 2:1-7.
63. Iovino F., Orihuela C.J., Moorlag H.E., Molema G., Bijlsma J.J. Interactions between blood-borne Streptococcus pneumoniae and the blood-brain barrier preceding meningitis. PLoS One 2013, 8:e68408.
64. Orihuela C.J., Mahdavi J., Thornton J., Mann B., Wooldridge K.G., Abouseada N., et al. Laminin receptor initiates bacterial contact with the blood-brain barrier in experimental meningitis models. J Clin Invest 2009, 119:1638-1646.
65. Mann B., Thornton J., Heath R., Wade K.R., Tweten R.K., Gao G., et al. Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein. J Infect Dis 2014, 209:1116-1125.
66. Uchiyama S., Carlin A.F., Khosravi A., Weiman S., Banerjee A., Quach D., et al. The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion. J Exp Med 2009, 206:1845-1852.
67. Iovino F., Molema G., Bijlsma J.J. Streptococcus pneumoniae interacts with pIgR expressed by the brain microvascular endothelium but does not co-localize with PAF receptor. PLoS One 2014, 9:e97914.
68. Iovino F., Molema G., Bijlsma J.J. Platelet endothelial cell adhesion molecule-1 (PECAM-1), a putative receptor for the adhesion of Streptococcus pneumoniae to the vascular endothelium of the blood-brain barrier. Infect Immun 2014, 82:3555-3566.
69. Ring A., Weiser J.N., Tuomanen E.I. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest 1998, 102:347-360.
70. Fillon S., Soulis K., Rajasekaran S., Benedict-Hamilton H., Radin J.N., Orihuela C.J., et al. Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology. J Immunol 2006, 177:6182-6191.
71. Gradstedt H., Iovino F., Bijlsma J.J. Streptococcus pneumoniae invades endothelial host cells via multiple pathways and is killed in a lysosome dependent manner. PLoS One 2013, 8:e65626.
72. Iovino F., Gradstedt H., Bijlsma J.J. The proteasome-ubiquitin system is required for efficient killing of intracellular Streptococcus pneumoniae by brain endothelial cells. MBio 2014, 5:e00984-14.
73. Orihuela C.J., Gao G., Francis K.P., Yu J., Tuomanen E.I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 2004, 190:1661-1669.
74. Gehre F., Leib S.L., Grandgirard D., Kummer J., Buhlmann A., Simon F., et al. Essential role of choline for pneumococcal virulence in an experimental model of meningitis. J Intern Med 2008, 264:143-154.
75. Hirst R.A., Gosai B., Rutman A., Guerin C.J., Nicotera P., Andrew P.W., et al. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis. J Infect Dis 2008, 197:744-751.
76. Zhou A., Wang H., Lan K., Zhang X., Xu W., Yin Y., et al. Apoptosis induced by pneumolysin in human endothelial cells involves mitogen-activated protein kinase phosphorylation. Int J Mol Med 2012, 29:1025-1030.
77. Mahdi L.K., Wang H., Van der Hoek M.B., Paton J.C., Ogunniyi A.D. Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice. J Clin Invest 2012, 122:2208-2220.
78. Tomlinson G., Chimalapati S., Pollard T., Lapp T., Cohen J., Camberlein E., et al. TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins. J Immunol 2014, 193:3736-3745.
79. Malley R., Henneke P., Morse S.C., Cieslewicz M.J., Lipsitch M., Thompson C.M., et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 2003, 100:1966-1971.
80. Letiembre M., Echchannaoui H., Ferracin F., Rivest S., Landmann R. Toll-like receptor-2 deficiency is associated with enhanced brain TNF gene expression during pneumococcal meningitis. J Neuroimmunol 2005, 168:21-33.
81. Koedel U., Angele B., Rupprecht T., Wagner H., Roggenkamp A., Pfister H.W., et al. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis. J Immunol 2003, 170:438-444.
82. Echchannaoui H., Frei K., Schnell C., Leib S.L., Zimmerli W., Landmann R. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 2002, 186:798-806.
83. Klein M., Obermaier B., Angele B., Pfister H.W., Wagner H., Koedel U., et al. Innate immunity to pneumococcal infection of the central nervous system depends on Toll-like receptor (TLR) 2 and TLR4. J Infect Dis 2008, 198:1028-1036.
84. Liu X., Chauhan V.S., Young A.B., Marriott I. NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae. Glia 2010, 58:839-847.
85. Latz E., Xiao T.S., Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013, 13:397-411.
86. Hoegen T., Tremel N., Klein M., Angele B., Wagner H., Kirschning C., et al. The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release. J Immunol 2011, 187:5440-5451.
87. Geldhoff M., Mook-Kanamori B.B., Brouwer M.C., Troost D., Leemans J.C., Flavell R.A., et al. Inflammasome activation mediates inflammation and outcome in humans and mice with pneumococcal meningitis. BMC Infect Dis 2013, 13:358.
88. Orihuela C.J., Fillon S., Smith-Sielicki S.H., El Kasmi K.C., Gao G., Soulis K., et al. Cell wall-mediated neuronal damage in early sepsis. Infect Immun 2006, 74:3783-3789.
89. Coutinho L.G., Grandgirard D., Leib S.L., Agnez-Lima L.F. Cerebrospinal-fluid cytokine and chemokine profile in patients with pneumococcal and meningococcal meningitis. BMC Infect Dis 2013, 13:326.
90. Tuomanen E., Liu H., Hengstler B., Zak O., Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985, 151:859-868.
91. Tuomanen E.I., Austrian R., Masure H.R. Pathogenesis of pneumococcal infection. N Engl J Med 1995, 332:1280-1284.
92. Jaber S.M., Hamed E.A., Hamed S.A. Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis. J Pediatr Neurosci 2009, 4:76-85.
93. Weber J.R., Angstwurm K., Burger W., Einhaupl K.M., Dirnagl U. Anti ICAM-1 (CD 54) monoclonal antibody reduces inflammatory changes in experimental bacterial meningitis. J Neuroimmunol 1995, 63:63-68.
94. Tuomanen E.I., Saukkonen K., Sande S., Cioffe C., Wright S.D. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 1989, 170:959-969.
95. Angstwurm K., Weber J.R., Segert A., Burger W., Weih M., Freyer D., et al. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats. Neurosci Lett 1995, 191:1-4.
96. Leib S.L., Leppert D., Clements J., Tauber M.G. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 2000, 68:615-620.
97. Leppert D., Leib S.L., Grygar C., Miller K.M., Schaad U.B., Hollander G.A. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis 2000, 31:80-84.
98. Bender A., Elstner M., Paul R., Straube A. Severe symptomatic aseptic chemical meningitis following myelography: the role of procalcitonin. Neurology 2004, 63:1311-1313.
99. Barichello T., Generoso J.S., Michelon C.M., Simoes L.R., Elias S.G., Vuolo F., et al. Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats. Exp Biol Med (Maywood) 2014, 239:225-231.
100. Liechti F.D., Grandgirard D., Leppert D., Leib S.L. Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis. Infect Immun 2014, 82:1710-1718.
101. Odio C.M., Faingezicht I., Paris M., Nassar M., Baltodano A., Rogers J., et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991, 324:1525-1531.
102. Tuomanen E. Adjuncts to the therapy of bacterial meningitis. Pediatr Infect Dis J 1990, 9:782-783.
103. Dandona P., Mohanty P., Hamouda W., Aljada A., Kumbkarni Y., Garg R. Effect of dexamethasone on reactive oxygen species generation by leukocytes and plasma interleukin-10 concentrations: a pharmacodynamic study. Clin Pharmacol Ther 1999, 66:58-65.
104. Bedford H., de Louvois J., Halket S., Peckham C., Hurley R., Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 2001, 323:533-536.
105. Kastenbauer S., Pfister H.W. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003, 126:1015-1025.
106. Nau R., Bruck W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002, 25:38-45.
107. Weber J.R., Tuomanen E.I. Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol 2007, 184:45-52.
108. 2 mediate brain cell apoptosis during meningitis. J Clin Invest 2002, 109:19-27.
109. Braun J.S., Novak R., Herzog K.H., Bodner S.M., Cleveland J.L., Tuomanen E.I. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 1999, 5:298-302.
110. Garrison S.P., Thornton J.A., Hacker H., Webby R., Rehg J.E., Parganas E., et al. The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsis. PLoS Pathog 2010, 6:e1001240.